Articles 2014-21

Will's Power FOUNDATION

CHAMPIONING LYMPHATIC Disease TREATMENT & RESEARCH FOR KIDS IN CANADA

continuation of academic Articles - 2014-2021

This is a continuation of the academic journal articles from the previous page. Papers are listed by date from most to least recent.

This is in no way meant to replace medical advice, rather it is a starting point for discussions with your medical team.

Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations

Kaitlyn Zenner 1 2, Dana M Jensen 3, Tori T Cook 3, Victoria Dmyterko 4, Randall A Bly 1 2,

Sheila Ganti 1 2 5, Ghayda M Mirzaa 4 6, William B Dobyns 4 6, Jonathan A Perkins 1 2,

James T Bennett 7 8 9

Genet Med. 2021 Jan;23(1):123-130. Epub 2020 Sep 4. PMID: 32884133 PMCID: PMC7796969

DOI: 10.1038/s41436-020-00943-8

https://pubmed.ncbi.nlm.nih.gov/32884133/

Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces . . .

Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels

Janet Crane, Jackie Manfredo, Elisa Boscolo, Mara Coyan, Clifford Takemoto, Maxim Itkin, Denise M Adams, Timothy D Le Cras

Pediatr Blood Cancer 2020 Sep;67(9):e28529. doi: 10.1002/pbc.28529. Epub 2020 Jul 7. PMID: 32634277 PMCID: PMC8554683 DOI: 10.1002/pbc.28529

https://pubmed.ncbi.nlm.nih.gov/32634277/

Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies-expert . . .

Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies-expert opinion consensus

Ionela Iacobas 1, Denise M Adams 2, Sheena Pimpalwar 3, Thuy Phung 1, Francine Blei 4, Patricia Burrows 5, Juan Carlos Lopez-Gutierrez 6, Michael A Levine 7, Cameron C Trenor3rd 2

Pediatr Blood Cancer 2020 Jan;67(1):e28036. doi: 10.1002/pbc.28036. Epub 2019 Oct 16. PMID: 31617676 DOI: 10.1002/pbc.28036

https://pubmed.ncbi.nlm.nih.gov/31617676/

Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout .

Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease

Kiersten W Ricci 1, Adrienne M Hammill 1, Paula Mobberley-Schuman 1, Stephen C Nelson 2, Julie Blatt 3, Julia L Glade Bender 4, Catherine C McCuaig 5, Anna Synakiewicz 6, Ilona J Frieden 7, Denise M Adams 8

Pediatr Blood Cancer 2019 May;66(5):e27614. doi: 10.1002/pbc.27614. Epub 2019 Jan 22. PMID: 30672136 PMCID: PMC6428616 DOI: 10.1002/pbc.27614

https://pubmed.ncbi.nlm.nih.gov/30672136/#:~:text=Conclusions%3A%20Sirolimus%20appears%20effe ctive%20at,and%20GSD%20with%20sirolimus%20treatment.

Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly

Somatic activating mutations in PIK3CA cause generalized lymphatic anomalyIn Special Collection: Angiogenesis , Inborn Errors of Immunity 2019 Article|December 27 2018
Lara Rodriguez-Laguna, Noelia Agra, Kristina Ibañez, Gloria Oliva-Molina, Gema Gordo, Noor Khurana, Devon Hominick, María Beato, Isabel Colmenero, Gonzalo Herranz, Juan M. Torres Canizalez, Rebeca Rodríguez Pena, Elena Vallespín, Rubén Martín-Arenas, Ángela del Pozo, Cristina Villaverde, Ana Bustamante, Carmen Ayuso, Pablo Lapunzina, Juan C. Lopez-Gutierrez, Michael T. Dellinger, Victor Martinez-Glez

J Exp Med (2019) 216 (2): 407–418. https://doi.org/10.1084/jem.20181353

https://rupress.org/jem/article/216/2/407/120340/Somatic-activating-mutations-in-PIK3CA-cause

Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with . .

Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer

Désirée Caselli 1, Maria Grazia Petris 2, Roberto Rondelli 3, Francesca Carraro 4,

Antonella Colombini 5, Paola Muggeo 6, Ottavio Ziino 7, Fraia Melchionda 3, Giovanna Russo 8,

Paolo Pierani 9, Elena Soncini 10, Raffaella DeSantis 11, Giulio Zanazzo 12, Angelica Barone 13,

Simone Cesaro 14, Monica Cellini 15, Rossella Mura 16, Giuseppe M Milano 17, Cristina Meazza 18, Maria P Cicalese 19, Serena Tropia 7, Salvatore De Masi 20, Elio Castagnola 21, Maurizio Aricò 22, Infectious Diseases Working Group of the Associazione Italiana Ematologia Oncologia Pediatrica

JPediatr 2014 Feb;164(2):389-92.e1. doi: 10.1016/j.jpeds.2013.10.021. Epub 2013 Nov 16. PMID: 24252793 DOI: 10.1016/j.jpeds.2013.10.021

https://pubmed.ncbi.nlm.nih.gov/24252793/#:~:text=Conclusion%3A%20A%20single%2Dday%20course ,cancer%20undergoing%20intensive%20chemotherapy%20regimens.